NasdaqGS:SRPT
NasdaqGS:SRPTBiotechs

Is Sarepta Therapeutics a Bargain After Its Recent 85% Stock Slide in 2025?

Ever wondered if Sarepta Therapeutics might finally be trading at a price that matches its potential? Let’s dig into what the numbers and the story say about its value right now. The stock has seen a 6.7% jump in the last week. However, this comes after steeper declines of 15.3% over the past month and nearly 85% year-to-date. This makes the current price feel especially intriguing or risky, depending on your outlook. Recent headlines have centered on Sarepta’s evolving lineup of gene...
NasdaqGS:CNTA
NasdaqGS:CNTABiotechs

Centessa Pharmaceuticals (CNTA) Raises $250 Million for Pipeline Expansion Is This a Turning Point?

Centessa Pharmaceuticals recently completed a significant follow-on equity offering, raising approximately US$250 million through the sale of more than 11.6 million American Depositary Shares at US$21.50 each, with additional purchase options granted to underwriters. This capital raise follows a period of increased research and development spending, with proceeds aimed at supporting the advancement of Centessa’s diverse pipeline targeting neurological and neuropsychiatric disorders. We'll...
NYSE:MOD
NYSE:MODAuto Components

Is Modine (MOD) Positioning Itself for an AI-Driven Future in Energy Infrastructure?

On November 12, 2025, Modine Manufacturing Company delivered a presentation at the Crypto & AI/Energy Infrastructure Conference in Miami, led by CEO Neil D. Brinker. The company's active engagement at a major event connecting AI and energy infrastructure highlights its ambitions to capitalize on key technology-driven growth sectors. We'll explore how Modine’s focus on data center and energy infrastructure solutions at this conference could impact its investment outlook. Find companies with...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Has Globalstar’s 133% Share Price Surge Made It Too Expensive in 2025?

Wondering if Globalstar’s rapid rise means the stock is now a hidden gem or if it is already too rich for your portfolio? You are not alone. Many investors are watching its valuation closely. The share price has increased 133.1% over the past year and is up 98.0% year-to-date, with a surge of 41.2% in just the last month. This suggests a significant change in market sentiment. Much of this momentum can be linked to recent headlines about the company’s technology partnerships...
NYSEAM:UAMY
NYSEAM:UAMYMetals and Mining

United States Antimony (UAMY) Is Down 11.3% After Landing $352 Million in Multi-Year Supply Deals

United States Antimony Corporation recently announced its third quarter 2025 results, reporting revenues of US$8.7 million and a net loss of US$4.78 million, while also securing two major five-year supply contracts with the U.S. government and a domestic industrial manufacturer valued at a combined US$352 million. The new US$106.7 million supply agreement with a U.S. industrial fabric manufacturer highlights growing industrial emphasis on reshoring critical mineral supply chains and seeking...
NasdaqGS:CRDO
NasdaqGS:CRDOSemiconductor

Credo Technology Group (CRDO) Is Down 11.1% After Launching Weaver to Address AI Memory Bottlenecks – Has the Bull Case Changed?

On November 3, 2025, Credo Technology Group Holding announced Weaver, an advanced memory fanout gearbox designed to dramatically increase memory bandwidth and density for AI accelerators and data centers, leveraging advanced 112G VSR SerDes and proprietary design. This launch directly addresses persistent memory bottlenecks limiting AI inference workloads, offering a unique approach that potentially elevates scalability and performance in next-generation data center applications. We'll...
NYSE:THC
NYSE:THCHealthcare

Tenet Healthcare (THC): Evaluating Valuation After Major Debt Refinancing and Balance Sheet Moves

Tenet Healthcare (THC) is taking major steps to strengthen its balance sheet, wrapping up new debt offerings and securing a multi-year revolving credit facility. These latest moves reshape the company’s financing landscape and extend its debt maturities. See our latest analysis for Tenet Healthcare. The buzz around Tenet Healthcare’s new financing moves has added to the stock’s momentum this year, with a share price now at $192.91 after a strong year-to-date gain of 54.1%. While shares...
NYSE:LEG
NYSE:LEGConsumer Durables

Leggett & Platt (LEG): Exploring Valuation as Investor Interest Grows

Leggett & Platt (LEG) shares have been relatively steady lately, attracting attention as investors weigh up the company’s current valuation compared to its performance over the past year. The stock’s moves hint at ongoing market curiosity. See our latest analysis for Leggett & Platt. Leggett & Platt’s share price has picked up slightly in recent weeks, hinting that some investors are warming up to the stock. However, the longer-term picture remains challenging. While the 1-month share price...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

How Investors May Respond To Mirum Pharmaceuticals (MIRM) Profitability, Raised Guidance, and Positive Liver Disease Data

Mirum Pharmaceuticals recently reported strong third-quarter financial results, including a swing to profitability and substantial year-over-year revenue growth, alongside raising its full-year 2025 revenue guidance to the upper end of its prior range. The company also announced new and positive clinical data for its key therapies, LIVMARLI and volixibat, to be featured at the American Association for the Study of Liver Diseases’ (AASLD) 2025 Liver Meeting, underscoring advances in...
NYSE:ZIM
NYSE:ZIMShipping

Should You Reassess ZIM After Recent 18% Rally and Industry Rate Volatility News?

Wondering if ZIM Integrated Shipping Services is a diamond in the rough or just another shipping stock? You are not alone, especially with value investors always on the hunt for a good deal. The stock has had quite a ride recently. It jumped 18.0% over the last month and 8.8% in the last week, yet remains down 31.3% year-to-date, hinting at shifts in sentiment and opportunities below the surface. Recent news has focused on industry-wide shipping rate volatility, as well...
NYSE:NYT
NYSE:NYTMedia

Strong Q3 Results and Share Buyback Might Change the Case for Investing in New York Times (NYT)

The New York Times Company recently announced past third-quarter earnings, reporting revenue of US$700.82 million and net income of US$81.65 million, both higher than the same period last year. Alongside these results, the company completed a significant share repurchase under its existing buyback plan, signaling ongoing capital return to shareholders. We'll examine how this combination of strong earnings growth and continued share buybacks could influence New York Times' investment...
NYSE:ST
NYSE:STElectrical

Sensata Technologies (ST): Exploring Valuation Following Cash Tender Offer Amendments and Strong Investor Response

Sensata Technologies (ST) has just shared early results from its latest cash tender offers. The company made headlines by removing the $300 million cap on its STBV 2029 Notes purchases. Investor demand was strong, with tenders exceeding the initial limit and prompting changes to the offer terms. See our latest analysis for Sensata Technologies Holding. While Sensata Technologies’ early tender results and removal of the 2029 Notes purchase cap highlighted strong investor engagement, recent...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Papa John’s (PZZA): New Results and 2025 Guidance Put Spotlight on Valuation Outlook

Papa John's International (PZZA) released its third quarter results along with new sales guidance for 2025, projecting global system-wide sales growth between 1% and 2%. This combined update offers investors a window into the company's current financial standing and future expectations. See our latest analysis for Papa John's International. After a tough earnings season and the launch of new menu items, Papa John’s share price return has cooled off, with a 1-month decline of 22.8% suggesting...
NYSE:BBU
NYSE:BBUIndustrials

Did Brookfield Business Partners' (BBU) Debt Reduction and Asset Recycling Shift Its Investment Narrative?

Brookfield Business Partners recently reported third quarter 2025 earnings, highlighting a reduction in net income to US$25 million loss and lower sales compared to the previous year, alongside the completion of a buyback program and a quarterly dividend announcement. An interesting detail is the successful capital recycling program, which generated over US$2 billion, enabled US$1 billion in debt repayments and new investments, and led to a stronger financial structure with higher equity and...
BATS:CBOE
BATS:CBOECapital Markets

How Investors Are Reacting To Cboe’s (CBOE) Landmark UCITS SFT Clearing Collaboration With BNY

Cboe Global Markets announced that its clearing house, Cboe Clear Europe, achieved a key milestone by onboarding BNY as the first Agent Lender to clear Securities Financing Transactions (SFTs) for UCITS clients and introduced a title transfer model tailored for these clients. This expansion positions Cboe to extend its SFT clearing services to a broader range of securities and jurisdictions, reflecting increased institutional engagement and product innovation. We'll examine how Cboe's...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

Revenue and Earnings Surge Could Be a Game Changer for TPG (TPG)

TPG Inc. recently reported third quarter 2025 results, showing revenue of US$1.22 billion and net income of US$67.14 million, both reflecting substantial increases from the same period a year earlier. Management credited these improvements to strong fundraising momentum and record capital deployment, which management believes provide increased margin stability and sustain performance-related earnings. We'll examine how TPG's significant revenue and net income growth this quarter may shift...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Assessing Palantir After 130% Rally and Expansion Into AI and Government Contracts

Wondering if Palantir stock is a hidden gem or if the story has already played out? Let's dig into whether the current price really stacks up to the company's fundamentals. After a remarkable 131.4% gain year-to-date and a 164.6% return over the past year, Palantir has certainly caught the market’s attention, even with a brief pullback of 3.1% in the last month. Much of this excitement follows Palantir’s recent expansion into several high-profile government contracts and its steady push into...
NYSE:BURL
NYSE:BURLSpecialty Retail

Burlington Stores (BURL): Examining Valuation After Recent Slowdown in Share Price Momentum

Burlington Stores (BURL) shares have shown slight movement lately, prompting some investors to revisit the retailer’s performance. The company’s stock has experienced mixed returns over the past month and continues to draw attention in the retail sector. See our latest analysis for Burlington Stores. While Burlington Stores’ share price return has been fairly muted recently, the bigger story is that momentum has slowed after a strong multi-year run. The company’s total shareholder return of...
NYSE:EVEX
NYSE:EVEXAerospace & Defense

A Fresh Look at Eve Holding (NYSE:EVEX) Valuation Following Bahrain Expansion Deal

Eve Holding (NYSE:EVEX) has signed a framework agreement with Bahrain’s Ministry of Transportation and Telecommunications, aiming to fast-track sustainable air mobility across the Middle East. The initiative paves the way for eVTOL operations and international expansion. See our latest analysis for Eve Holding. While Eve Holding’s agreement with Bahrain marks an exciting step towards international expansion, the company’s share price has faced significant pressure recently, with a 22.6%...
NYSE:BRBR
NYSE:BRBRPersonal Products

Assessing BellRing Brands (BRBR) Valuation After Recent Share Price Decline

BellRing Brands (BRBR) shares have been on a slide this month, losing over 21% in the past month and nearly 30% over the past 3 months. The stock’s recent journey has caught the attention of investors searching for value opportunities. See our latest analysis for BellRing Brands. Zooming out, BellRing Brands has seen momentum fade, with a year-to-date share price return of -63.86% and a 1-year total shareholder return of -62.60%, even though it has still posted gains over the past three and...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc Health (TDOC): Evaluating Valuation After a 23% 1-Month Share Price Decline

Teladoc Health (TDOC) shares have lost around 23% over the past month, following a steady string of losses in the digital health sector. Investors are now watching for signs of stabilization or a shift in market sentiment. See our latest analysis for Teladoc Health. Teladoc Health’s share price has suffered a sharp 1-month drop of 22.6%, adding to a challenging year where its total shareholder return is down nearly 25% and momentum continues to fade. The latest decline reflects cautious...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

Is Peloton’s Formula 1 Las Vegas Grand Prix Partnership Shifting the Investment Case for PTON?

Peloton Interactive and the Formula 1 Las Vegas Grand Prix recently announced a collaboration to deliver exclusive fitness classes and experiences during the Grand Prix weekend, including onsite and virtual programming such as trackside workouts and scenic rides around the Las Vegas Strip Circuit. This partnership not only aligns Peloton with a global sports event but also extends the reach of its new Cross Training Series and leverages high-impact media exposure in a location known for its...
NasdaqGS:DCOM
NasdaqGS:DCOMBanks

Dime Community Bancshares (DCOM): Assessing Valuation After Universal Shelf Registration Filing

Dime Community Bancshares (DCOM) recently filed a universal shelf registration, which allows it to issue debt, equity, and other financial instruments. This move could set the stage for future financing opportunities and may influence how investors view the stock. See our latest analysis for Dime Community Bancshares. Over the past year, Dime Community Bancshares’ share price has trended lower, down 10.5% year-to-date and delivering a -16.5% total shareholder return. This comes despite the...
NasdaqGM:URGN
NasdaqGM:URGNBiotechs

UroGen Pharma (URGN): Assessing Valuation After 37% Share Price Surge in the Past Month

UroGen Pharma (URGN) has caught the attention of investors recently, with shares showing significant momentum over the past month. The company’s stock price has surged 37%, far outpacing broader industry trends and prompting fresh interest in its underlying story. See our latest analysis for UroGen Pharma. Zooming out, UroGen Pharma’s 37% share price rise over the past month has pulled it well ahead of the sector, building on a stellar year-to-date share price return of 122%. That momentum is...